Data on the identification of VRK2 as a mediator of PD-1 function
Therapeutic programmed cell death protein 1 (PD-1) blockade enhances T cell mediated anti-tumor immunity, but many patients do not respond, and a significant proportion develops inflammatory toxicities. To develop better therapeutics and to understand the signaling pathways downstream of PD-1 we per...
Main Authors: | Michael Peled, Kieran Adam, Adam Mor |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-08-01
|
Series: | Data in Brief |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352340921004522 |
Similar Items
-
Down-regulation of VRK1 Expression by siRNA Suppresses BANF1 Expression and Proliferation and Migration Abilities of Esophageal Squamous Cell Carcinoma Cells
by: GENG Jie, et al.
Published: (2019-01-01) -
Identification of VRK1 as a New Neuroblastoma Tumor Progression Marker Regulating Cell Proliferation
by: Ana Colmenero-Repiso, et al.
Published: (2020-11-01) -
VRK1 Depletion Facilitates the Synthetic Lethality of Temozolomide and Olaparib in Glioblastoma Cells
by: Elena Navarro-Carrasco, et al.
Published: (2021-06-01) -
DNA Aptamers against Vaccinia-Related Kinase (VRK) 1 Block Proliferation in MCF7 Breast Cancer Cells
by: Rebeca Carrión-Marchante, et al.
Published: (2021-05-01) -
HNRNP A1 Promotes Lung Cancer Cell Proliferation by Modulating <i>VRK1</i> Translation
by: Hye Guk Ryu, et al.
Published: (2021-05-01)